You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Jun 1, 2026
Sale
Calculated transaction value
$375.75K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
May 29, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$556.82
May 29, 2026
First close after public filing
$540.05
Jun 2, 2026
30-day return after filing
+1.31%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 680 shares @ $552.58
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000065
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.65M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | May 29, 2026 | $1.39M |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $555.59K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $256.62K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $153.61K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $422.64K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $883.71K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $543.62K |
| United Therapeutics Corp UTHR Current | Sale | May 29, 2026 | $375.75K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $455.72K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $453.08K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $512.06K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $469.96K |
| United Therapeutics Corp UTHR | Sale | May 29, 2026 | $179.01K |
| United Therapeutics Corp UTHR | Exercise | May 29, 2026 | $0 |